Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
Morgan-Linnell SK, Becnel Boyd L, Steffen D, Zechiedrich L.
Morgan-Linnell SK, et al. Among authors: zechiedrich l.
Antimicrob Agents Chemother. 2009 Jan;53(1):235-41. doi: 10.1128/AAC.00665-08. Epub 2008 Oct 6.
Antimicrob Agents Chemother. 2009.
PMID: 18838592
Free PMC article.
In the accompanying report, we found that ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant E. coli clinical isolates were very high and widely varied (L. Becnel Boyd, M. J. Maynard, S. K. Morgan-Linnell, L. B. Horton, R. …
In the accompanying report, we found that ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant E. c …